Magkouta, S.F.; Vaitsi, P.C.; Iliopoulou, M.P.; Pappas, A.G.; Kosti, C.N.; Psarra, K.; Kalomenidis, I.T.
MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental Mesothelioma. Cancers 2023, 15, 4962.
https://doi.org/10.3390/cancers15204962
AMA Style
Magkouta SF, Vaitsi PC, Iliopoulou MP, Pappas AG, Kosti CN, Psarra K, Kalomenidis IT.
MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental Mesothelioma. Cancers. 2023; 15(20):4962.
https://doi.org/10.3390/cancers15204962
Chicago/Turabian Style
Magkouta, Sophia F., Photene C. Vaitsi, Marianthi P. Iliopoulou, Apostolos G. Pappas, Chrysavgi N. Kosti, Katherina Psarra, and Ioannis T. Kalomenidis.
2023. "MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental Mesothelioma" Cancers 15, no. 20: 4962.
https://doi.org/10.3390/cancers15204962
APA Style
Magkouta, S. F., Vaitsi, P. C., Iliopoulou, M. P., Pappas, A. G., Kosti, C. N., Psarra, K., & Kalomenidis, I. T.
(2023). MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental Mesothelioma. Cancers, 15(20), 4962.
https://doi.org/10.3390/cancers15204962
